There’s still no generic Ozempic, but a lower-priced daily injected GLP-1 is coming
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...
FDA: Knockoff versions of Lilly obesity drug must come off the market
The federal government is phasing out off-brand copies of two blockbuster drugs used to treat obesity and diabetes ...
Potential 'fungal contamination' leads to nationwide recall of popular brand of eye drops: FDA
A popular brand of eye drops is being recalled nationwide after a consumer reported a "foreign material" was found in a ...
FDA: Weight loss drug Zepbound, diabetes drug Mounjaro no longer in shortage
Consumers who take copies of the weight loss drug Zepbound and diabetes drug Mounjaro will need to find a new source for ...
ScienceAlert on MSN5 小时
World's Most Common Pain Relief Drug May Induce Risky Behavior
A cetaminophen, also known as paracetamol and sold widely under the brand names Tylenol and Panadol, may also increase ...
The shortage of popular weight loss drug tirzepatide is over, FDA says. Patients could see ...
The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to ...
Lilly’s US weight-loss drug shortage ends, curtailing copycats
Eli Lilly and Co.’s diabetes and weight-loss drugs Mounjaro and Zepbound are no longer in short supply in the US, which means ...
US FDA says Lilly’s weight-loss drug shortage is resolved
The U.S. Food and Drug Administration said on Thursday there was no longer a shortage of Eli Lilly’s (LLY.N) blockbuster ...
Milwaukee Journal Sentinel2 天
FDA approves generic in same class as Ozempic for diabetes. Could it ease shortage, price?
follows the approval of the generic GLP-1 exanatide last month, sold under the name Byetta. Neither drug is considered as effective as the brand-name weekly injections sold for diabetes and weight ...